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types of Indian Isolates
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Agarwal, A. Mohan, K. Luthra, V.K. Iyer
AIIMS, New Delhi, India
Background: Pneumocystis carinii Pneumonia (PCP)
caused by an opportunistic agent Pneumocystis jirovecii is
one of the most serious respiratory infections in immuno-
compromised patients including HIV infected individuals.
Enormous gaps still exist in understanding the basic biology
of the organism and epidemiology of PCP due to non-
availability of an appropriate propagation system. In the
present study, we carried out molecular detection of the
organism using two multicopy and one single copy gene. Fur-
ther genotypic study was performed on some of the isolates
to assess the genotypes.
Methods: From November 2005 to October 2006, 114
different respiratory specimens were collected from 90
patients with various underlying conditions and a clinical
suspicion of PCP. PCR was done for three independent gene
loci including two multicopy i.e. Major Surface Glycoprotein
(MSG) and mitochondrial Large subunit rRNA (mtLSUrRNA)
and one single copy, internal transcribed spacer (ITS)
region
Results: Single round MSG and mtLSUrRNA PCR showed
9 positive isolates. External round of ITS PCR detected 6
cases while only nested round could detect all 9 cases. On
applying nested PCR for mtLSUrRNA and ITS PCR we detected
5 additional cases. We further sequenced six isolates for
mtLSUrRNA gene. Different genotypes of Pneumocystis were
distinguished by identifying polymorphisms at position 85
and 248 of mtLSUrRNA. Two genotypes i.e. type 2 (5/6) and
3, (1/6) were observed among the six isolates. Also, one of
our previous isolate showed genotype 1.
Conclusion: Thus, among multicopy genes, MSG and mtL-
SUrRNA appears to be equally sensitive while in case of single
copy ITS a nested PCR assay is required. In our present study,
genotype 2 was more frequently detected (5/7), followed by
type 3 and 1(1/7) and a prospective study with large number
of patients is being carried out in our centre to address this
issue. To our knowledge this is the ﬁrst study from South Asia
describing genotypes of isolates of P. jirovecii .
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Background: Hearing loss in HIV positive patients have
been reported. However, these reports were hearing loss
caused by sudden hearing loss, Ramsay Hunt syndrome, and
so on. We investigated hearing loss in HIV positive patients
to know hearing loss possibility other than sudden hearing
loss, Ramsay Hunt syndrome, and so on.
Methods: One hundred ﬁfty seven patients were enrolled
in this study. They consulted our hospital from April in 2006
to March in 2008. Some patients suffered from sensorineu-
ral hearing loss caused by sudden deafness, Ramsay-Hunt
syndrome and so on. This study also includes patients
which do not complaint of hearing loss. Usual otolaryngo-
logical examination and blood tests were examined. Their
ear membranes, nasal cavity and oral cavity were checked
up. Pure-tone audiometry was examined in all patients.
Electronystagmogram including caloric testing were done in
some patients suffered from hearing loss. In addition, CD4
T-cell counts and RNA copy numbers were investigated by
blood test
Results: Patients suffered from sudden deafness,
Ramsay-Hunt syndrome or Meniere’s disease revealed ipsi-
lateral sensorineural healing loss. Some patients other than
these patients showed bilateral sensorineural hearing loss.
Usually their high-tone hearing levels were deteriorated. We
investigated the relationship between hearing levels and
CD4 T-cell counts. The hearing loss was more severe in
patients with low CD4 T-cell counts.
Conclusion: Severe HIV positive patients more often suf-
fered from sensorineural hearing loss.
doi:10.1016/j.ijid.2008.05.1366
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Tuberculosis (TB) is the most common opportunistic
infection in Human Immunodeﬁciency Virus (HIV)/Acquired
Immunodeﬁciency Syndrome (AIDS). There is an estimated
11.5 million people co-infected with HIV/TB with the high-
est burden in Sub-Saharan Africa. The accessibility of world
travel, the displacement of communities because of conﬂict,
war and famine as well as changes to Australian Govern-
ment’s immigration policies have meant that Australia is
not immune to this world trend. Three subjects that were
HIV positive and had suspected or conﬁrmed Mycobacterium
tuberculosis disease on the South Australian Tuberculosis
Service database were retrospectively studied. The diagno-
sis of TB was made after the diagnosis of HIV in all three
cases. Two had typical x-ray ﬁndings consistent with TB.
The possible place of acquisition differed between all three.
One was treated for TB prior to HIV, the remaining had HIV
treatment commenced prior to TB treatment. All three had
similar triple therapy for HIV. Two had conﬁrmed M yyyytu-
berculosis on culture with one showing partial resistance to
isoniazid. All three were commenced on standard quadru-
ple therapy, moxiﬂoxacin and streptomycin was added until
drug susceptibility conﬁrmation for the third. Treatment was
halted temporarily in two due to complications arising from
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HIV/TB therapy. The duration of therapy ranged from six
months to two years. Each of the three subjects highlighted
the difﬁculties to adequately manage the HIV/TB patient
and the infrastructure needed to support this level of care.
With the HIV/AIDS pandemic threatening to destabilize con-
trol of TB we should be supporting initiatives to improve TB
and HIV programs in resource poor settings with a focus on
preventive measures.
doi:10.1016/j.ijid.2008.05.1367
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Background: TB is the most common and serious HIV
related complication. It is estimated that about half of TB
cases in Uganda are co-infected with HIV and about 30%
of the HIV-related deaths are attributed to TB. However,
HIV and TB diagnosis programs are not traditionally inte-
grated. The recently launched national policy guidelines
for TB/HIV collaborative activities are aimed at integrat-
ing diagnosis, care and treatment for TB/HIV co-infected
patients. The Mulago-Mbarara Teaching Hospitals’ Joint AIDS
Program (MJAP) has been providing integrated routine HIV
testing and counselling, and TB screening for medical inpa-
tients in Mulago hospital since March 2005.
Method: All patients on medical wards in Mulago are
routinely offered HIV testing and counselling. Patients pre-
senting with a history of cough for more than three weeks
are also screened for TB by sputum microscopy. Patients
with HIV infection are started on cotrimoxazole prophylaxis,
those who are co-infected with TB and HIV are referred to
the TB HIV clinic were they receive both TB and HIV care
and treatment. We analysed data for 379 patients to assess
the number of new TB and HIV infections identiﬁed.
Result: Among the 379 patients, 200 (53%) did not know
their HIV/TB status on admission, and received both HIV
testing and TB screening. Of these, 24 (11%) were co-
infected with TB and HIV, 70 (35%) had HIV infection alone
while 22 (11%) had TB infection alone. Out of the 159
patients who were known to be HIV-Infected on admission,
40 (25%) had TB infection. Overall, 64 out of the 379 patients
(17%) were co-infected with TB and HIV. Among the 253 HIV
infected patients 64 (25%) had smear positive TB.
Conclusion: Integration of TB and HIV diagnosis is feasible
and provides an opportunity for appropriate linkage to care
for TB-HIV co-infected patients.
doi:10.1016/j.ijid.2008.05.1368
